Stevanato (STVN) Stock Analysis
NYSEHealthcareMedical - Instruments & Supplies
What Stevanato does
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Key metrics
ETFs linked to STVN
Broad-market and Healthcare sector ETFs an investor holding Stevanato is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how STVN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze STVN in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Stevanato?
- Stevanato trades under the ticker STVN on NYSE.
- Which exchange is STVN listed on?
- STVN is listed on NYSE.
- What sector does Stevanato operate in?
- Stevanato is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
- How can PortView help analyze STVN in a portfolio?
- PortView shows STVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.